Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
Adolescent
Aged
Canada
Cancer Survivors
/ psychology
Female
Health Services Needs and Demand
/ statistics & numerical data
Humans
Male
Middle Aged
Needs Assessment
Neoplasm Staging
Patient Care
Quality of Life
/ psychology
Research
Surveys and Questionnaires
Time
Urinary Bladder Neoplasms
/ psychology
Bladder cancer
Cancer survivorship
Informational needs
Patient education
Quality of life
Supportive care needs
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
15
08
2018
accepted:
14
01
2019
pubmed:
16
2
2019
medline:
20
11
2019
entrez:
16
2
2019
Statut:
ppublish
Résumé
To date, little research has examined the quality of life and cancer-associated needs of bladder cancer patients. The objective of the current study was to assess the quality of life (QoL), informational needs, and supportive care needs (SCN) in a large sample of muscle invasive (MIBC) and non-muscle invasive (NMIBC) bladder cancer survivors across the treatment trajectory (newly diagnosed and undergoing treatment, post-treatment follow-up, and treatment for advanced/recurrent disease). Questionnaires were distributed to a convenience sample of patients registered with Bladder Cancer Canada, the Princess Margaret Cancer Centre, or The Ottawa Hospital. Eligibility criteria included being > 18 years of age, English-speaking, and diagnosed with bladder cancer. The questionnaire included an adapted tool to measure informational needs, and validated measures for QoL (Bladder Utility Symptom Scale, BUSS) and SCN (Cancer Survivors' Unmet Needs Measure, CaSUN). QoL scores and unmet needs were calculated and compared between disease groups and cancer trajectory groups. Of the 1126 surveys distributed, 586 were completed (response = 52%). Mean age was 67.3 ± 10.2 years, and 401 participants (68.7%) were male. The mean QoL score (BUSS) for the sample was 78.1 ± 17.9 (median 81.7). Respondents with MIBC had significantly lower QoL scores compared to NMIBC. Further, scores differed across the cancer phase groups with the follow-up surveillance group having significantly higher QoL scores compared to the newly diagnosed and advance/recurrent disease groups. The ten most highly ranked informational needs were from the medical, physical, and practical domains. Eighty-eight percent (95% CI 85-91%) of respondents reported at least one SCN, with a median of 12. Over half of the participants (54%, 95% CI 49-59%) had at least one unmet need and 15% had ≥ 10 unmet needs. Newly diagnosed participants had the highest number of unmet needs. We found that the number of unmet supportive care needs and quality of life differed across cancer trajectory and disease groups. Future efforts should focus on the development and evaluation of tailored resources and programs to address the needs of people diagnosed and treated for BC.
Sections du résumé
BACKGROUND
BACKGROUND
To date, little research has examined the quality of life and cancer-associated needs of bladder cancer patients. The objective of the current study was to assess the quality of life (QoL), informational needs, and supportive care needs (SCN) in a large sample of muscle invasive (MIBC) and non-muscle invasive (NMIBC) bladder cancer survivors across the treatment trajectory (newly diagnosed and undergoing treatment, post-treatment follow-up, and treatment for advanced/recurrent disease).
METHODS
METHODS
Questionnaires were distributed to a convenience sample of patients registered with Bladder Cancer Canada, the Princess Margaret Cancer Centre, or The Ottawa Hospital. Eligibility criteria included being > 18 years of age, English-speaking, and diagnosed with bladder cancer. The questionnaire included an adapted tool to measure informational needs, and validated measures for QoL (Bladder Utility Symptom Scale, BUSS) and SCN (Cancer Survivors' Unmet Needs Measure, CaSUN). QoL scores and unmet needs were calculated and compared between disease groups and cancer trajectory groups.
RESULTS AND LIMITATIONS
CONCLUSIONS
Of the 1126 surveys distributed, 586 were completed (response = 52%). Mean age was 67.3 ± 10.2 years, and 401 participants (68.7%) were male. The mean QoL score (BUSS) for the sample was 78.1 ± 17.9 (median 81.7). Respondents with MIBC had significantly lower QoL scores compared to NMIBC. Further, scores differed across the cancer phase groups with the follow-up surveillance group having significantly higher QoL scores compared to the newly diagnosed and advance/recurrent disease groups. The ten most highly ranked informational needs were from the medical, physical, and practical domains. Eighty-eight percent (95% CI 85-91%) of respondents reported at least one SCN, with a median of 12. Over half of the participants (54%, 95% CI 49-59%) had at least one unmet need and 15% had ≥ 10 unmet needs. Newly diagnosed participants had the highest number of unmet needs.
CONCLUSION
CONCLUSIONS
We found that the number of unmet supportive care needs and quality of life differed across cancer trajectory and disease groups. Future efforts should focus on the development and evaluation of tailored resources and programs to address the needs of people diagnosed and treated for BC.
Identifiants
pubmed: 30767131
doi: 10.1007/s00520-019-4649-z
pii: 10.1007/s00520-019-4649-z
pmc: PMC6726665
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3877-3885Commentaires et corrections
Type : CommentIn
Références
Malats N, Real FX (2015) Epidemiology of bladder cancer. Hematol Oncol Clin North Am 29(2):177–189 vii
doi: 10.1016/j.hoc.2014.10.001
pubmed: 25836927
Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234–241
doi: 10.1016/j.eururo.2012.07.033
pubmed: 22877502
Porter MP, Wei JT, Penson DF (2005) Quality of life issues in bladder cancer patients following cystectomy and urinary diversion. Urol Clin North Am 32(2):207–216
doi: 10.1016/j.ucl.2005.01.002
pubmed: 15862618
Thulin H, Kreicbergs U, Wijkstrom H, Steineck G, Henningsohn L (2010) Sleep disturbances decrease self-assessed quality of life in individuals who have undergone cystectomy. J Urol 184(1):198–202
doi: 10.1016/j.juro.2010.03.009
pubmed: 20478603
Thulin H, Kreicbergs U, Onelov E, Ahlstrand C, Carringer M, Holmang S et al (2011) Defecation disturbances after cystectomy for urinary bladder cancer. BJU Int 108(2):196–203
doi: 10.1111/j.1464-410X.2010.09815.x
pubmed: 21050359
Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A (2003) Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res 12(6):675–688
doi: 10.1023/A:1025144617752
pubmed: 14516177
Shih C, Porter MP (2011) Health-related quality of life after cystectomy and urinary diversion for bladder cancer. Ther Adv Urol 2011:715892
Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G (2001) Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study. Eur Urol 40(2):151–162
doi: 10.1159/000049766
pubmed: 11528192
Henningsohn L, Wijkstrom H, Steven K, Pedersen J, Ahlstrand C, Aus G et al (2003) Relative importance of sources of symptom-induced distress in urinary bladder cancer survivors. Eur Urol 43(6):651–662
doi: 10.1016/S0302-2838(03)00135-0
pubmed: 12767367
Mohamed NE, Pisipati S, Lee CT, Goltz HH, Latini DM, Gilbert FS et al (2016) Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices. Urol Oncol 34(12):531 e7- e14
doi: 10.1016/j.urolonc.2016.06.010
pubmed: 27449687
Mohamed NE, Chaoprang Herrera P, Hudson S, Revenson TA, Lee CT, Quale DZ, Zarcadoolas C, Hall SJ, Diefenbach MA (2014) Muscle invasive bladder cancer: examining survivor burden and unmet needs. J Urol 191(1):48–53
doi: 10.1016/j.juro.2013.07.062
pubmed: 23911603
Lee CT, Mei M, Ashley J, Breslow G, O'Donnell M, Gilbert S, Lemmy S, Saxton C, Sagalowsky A, Sansgiry S, Latini DM, Bladder Cancer Think Tank., Bladder Cancer Advocacy Network (2012) Patient resources available to bladder cancer patients: a pilot study of healthcare providers. Urology 79(1):172–177
doi: 10.1016/j.urology.2011.07.1405
pubmed: 21996109
EORTC Quality of Life Department. Bladder Cancer: EORTC QLQ-NMIBC24, EORTC QLQ-BLM30 Ave. E. Mounier 83, B.11, 1200 Brussels, BELGIUM, [Available from: http://groups.eortc.be/qol/bladder-cancer-eortc-qlq-nmibc24-eortc-qlq-blm30
Mansson A, Davidsson T, Hunt S, Mansson W (2002) The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int 90(4):386–390
doi: 10.1046/j.1464-410X.2002.02899.x
pubmed: 12175394
Guren MG, Wiig JN, Dueland S, Tveit KM, Fossa SD, Waehre H et al (2001) Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer. Eur J Surg Oncol 27(7):645–651
doi: 10.1053/ejso.2001.1195
pubmed: 11669593
Perlis N (2013) Developing the bladder utility symptom scale: a multiattribute health state classification system for bladder cancer. UofT, Toronto
Perlis N, Krahn MD, Boehme KE, Alibhai SMH, Jamal M, Finelli A, Sridhar SS, Chung P, Gandhi R, Jones J, Tomlinson G, Bremner KE, Kulkarni G (2018) The bladder utility symptom scale: a novel patient reported outcome instrument for bladder Cancer. J Urol 200(2):283–291
doi: 10.1016/j.juro.2018.03.006
pubmed: 29530786
Dillman DA (1999) Mail and Internet surveys - the tailored design method. Wiley & Sons, New York
Dillman DA (2007) Mail and internet surveys: the tailored design method 2007 update with new internet, visual, and mixed-mode guide. Hoboken, New Jersey, John Wiley & Sons, Inc
Steele R, Fitch MI (2008) Supportive care needs of women with gynecologic cancer. Cancer Nurs 31(4):284–291
doi: 10.1097/01.NCC.0000305743.64452.30
pubmed: 18600115
Papadakos J, McQuestion M, Gokhale A, Damji A, Trang A, Abdelmutti N, Ringash J (2018) Informational needs of head and neck cancer patients. J Cancer Educ 33(4):847–856
doi: 10.1007/s13187-017-1176-9
pubmed: 28155041
Papadakos J, Urowitz S, Olmstead C, Jusko Friedman A, Zhu J, Catton P (2015) Informational needs of gastrointestinal oncology patients. Health Expect 18(6):3088–3098
doi: 10.1111/hex.12296
pubmed: 25382413
Papadakos J, Bussiere-Cote S, Abdelmutti N, Catton P, Friedman AJ, Massey C et al (2012) Informational needs of gynecologic cancer survivors. Gynecol Oncol 124(3):452–457
doi: 10.1016/j.ygyno.2011.10.030
pubmed: 22047740
Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Lo SK, Wain G (2007) The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ unmet needs measure). Psychooncology 16(9):796–804
doi: 10.1002/pon.1137
pubmed: 17177268
Tang ST, Chang WC, Chen JS, Su PJ, Hsieh CH, Chou WC (2014) Trajectory and predictors of quality of life during the dying process: roles of perceived sense of burden to others and posttraumatic growth. Support Care Cancer 22(11):2957–2964
doi: 10.1007/s00520-014-2288-y
pubmed: 24865877
Mohamed NE, Gilbert F, Lee CT, Sfakianos J, Knauer C, Mehrazin R, Badr H, Wittmann D, Downs T, Berry D, Given B, Wiklund P, Steineck G (2016) Pursuing quality in the application of bladder cancer quality of life research. Bladder Cancer 2(2):139–149
doi: 10.3233/BLC-160051
pubmed: 27376136
pmcid: 4927895
Mazzotti E, Antonini Cappellini GC, Buconovo S, Morese R, Scoppola A, Sebastiani C, Marchetti P (2012) Treatment-related side effects and quality of life in cancer patients. Support Care Cancer 20(10):2553–2557
doi: 10.1007/s00520-011-1354-y
pubmed: 22270087
Edmondson AJ, Birtwistle JC, Catto JWF, Twiddy M (2017) The patients’ experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence. J Cancer Surviv 11(4):453–461
doi: 10.1007/s11764-017-0603-6
pubmed: 28213769
pmcid: 5500680
Cerruto MA, D'Elia C, Cacciamani G, De Marchi D, Siracusano S, Iafrate M et al (2014) Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit. Health Qual Life Outcomes 12:46
doi: 10.1186/1477-7525-12-46
pubmed: 24708662
pmcid: 3991923
Foley KL, Farmer DF, Petronis VM, Smith RG, McGraw S, Smith K, Carver CS, Avis N (2006) A qualitative exploration of the cancer experience among long-term survivors: comparisons by cancer type, ethnicity, gender, and age. Psychooncology 15(3):248–258
doi: 10.1002/pon.942
pubmed: 15940742
Hodgkinson K, Butow P, Hunt G, Pendlebury S, Hobbs K, Wain G (2006) Breast cancer survivors’ supportive care needs 2-10 years after diagnosis. Support Care Cancer 15(5):515–523
doi: 10.1007/s00520-006-0170-2
pubmed: 17120068
Giuliani M, McQuestion M, Jones J, Papadakos J, Le LW, Alkazaz N et al (2016) Prevalence and nature of survivorship needs in patients with head and neck cancer. Head Neck 38(7):1097–1103
doi: 10.1002/hed.24411
pubmed: 26894614
Hodgkinson K, Butow P, Fuchs A, Hunt GE, Stenlake A, Hobbs KM, Brand A, Wain G (2007) Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol 104:381–389
doi: 10.1016/j.ygyno.2006.08.036
pubmed: 17027072
Soothill K, Morris SM, Harman J, Francis B, Thomas C, McIllmurray MB (2001) The significant unmet needs of cancer patients: probing psychosocial concerns. Support Care Cancer 9(8):597–605
doi: 10.1007/s005200100278
pubmed: 11762970
Berry DL, Nayak M, Halpenny B, Harrington S, Loughlin KR, Chang P, Rosenberg JE, Kibel AS (2015) Treatment decision making in patients with bladder cancer. Bladder Cancer 1(2):151–158
doi: 10.3233/BLC-150029
pubmed: 27376115
pmcid: 4927892
Skea ZC, Maclennan SJ, Entwistle VA, N'Dow J (2014) Communicating good care: a qualitative study of what people with urological cancer value in interactions with health care providers. Eur J Oncol Nurs 18(1):35–40
doi: 10.1016/j.ejon.2013.09.009
pubmed: 24172757
Gold DT, McClung B (2006) Approaches to patient education: emphasizing the long-term value of compliance and persistence. Am J Med 119(4 Suppl 1):S32–S37
doi: 10.1016/j.amjmed.2005.12.021
pubmed: 16563940
Devine EC, Westlake SK (1995) The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 22(9):1369–1381
pubmed: 8539178
Jacobsen PB, Wagner LI (2012) A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol : official journal of the American Society of Clinical Oncology 30(11):1154–1159
doi: 10.1200/JCO.2011.39.5046
Botti M, Endacott R, Watts R, Cairns J, Lewis K, Kenny A (2006) Barriers in providing psychosocial support for patients with cancer. Cancer Nurs 29(4):309–316
doi: 10.1097/00002820-200607000-00010
pubmed: 16871099